603983.SH
丸美生物
SSE · Consumer Defensive · Household & Personal Products · CN
CNY 26.28
−1.79%Year over year
Reported trailing growth
- Revenue
- +10.7%
- EBITDA
- —
- EBIT
- -39.2%
- EPS
- -42.3%
- Free cash flow
- +392.6%
- Operating cash flow
- +19.7%
Forward estimates
Based on analyst estimates
- Revenue
- -47.1%
- EBITDA
- -52.3%
- EPS
- -49.5%
Three-year CAGR
- Revenue
- +25.9%
- EBITDA
- +15.3%
- EBIT
- +12.7%
- Net income
- +12.4%
- EPS
- +13.0%
- Free cash flow
- -9.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026